Successful explantation of a corneal microlens for presbyopia and implantation of a trifocal IOL in a patient who developed ...
OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain (NCP) and for inflammatory eye ...
Researchers at the University of Granada have developed corneal implants from fish scales with promising results in the laboratory and in animals. The finding opens a way to reduce dependence on ...
Background Ocular chronic graft versus host disease (oGVHD) seriously affects ocular surface, which often results in corneal epithelial damage. The purpose of this study is to evaluate corneal ...
Bacteria live throughout the human body. The eye was long thought to be an exception. Dr. Anthony St. Leger, a professor of ...
Recurrent corneal erosions (RCE) is a common condition in which the patient typically suffers from episodes of sudden eye pain, usually upon first awakening, accompanied by redness, photophobia, and ...
Serious diseases affecting the transparent part of the eye, called the cornea, are very difficult to treat because this ...
Analysts from Lucid Capital, H.C. Wainwright, and B. Riley Securities have all repeated ‘Buy’ ratings on OKYO Pharma Ltd ...
University of Pittsburgh School of Medicine researchers have developed an early-stage, experimental "living eye drop" that uses naturally occurring eye bacteria to support corneal wound healing. The ...
MADRID () - Researchers at Spain's University of Granada have developed an artificial cornea made from the scales of several ...
Faridabad: Corneal blindness is the second leading cause of blindness in India with a current burden of 1.1 million people. The incidence rate of corneal blindness in India has seen an increase in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results